By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

YEAR FOUNDED:

1858

LEADERSHIP:

Founder: Edward Robinson Squibb

CEO: Giovanni Caforio, MD

CFO: Charles Bancroft

CLINICAL TRIAL:

Please click here for clinical trial information.

JOB OPPORTUNITY:

Please click here for Bristol-Myers Squibb job opportunities.

PRODUCTS:

Please click here to see all products.

For more information, visit
www.bms.com and follow us on www.twitter.com/BMSNEWS.

FOLLOW BRISTOL-MYERS SQUIBB:





Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb
Employees:
Symbol: BMY
 





Collaborations

Gilead 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech  - Cancer

Gilead (Seattle, WA) 





Company News
Exelixis (EXEL) And Bristol-Myers Squibb (BMY) Enter Clinical Collaboration for Late-Stage Combination Trial in First-Line Renal Cell Carcinoma 2/27/2017 6:57:07 AM
Bristol-Myers Squibb (BMY) Expands International Immuno-Oncology Network (II-ON) With Addition Of Columbia University Medical Center And Peter MacCallum Cancer Centre 2/27/2017 6:53:24 AM
Is Anyone Really Shopping For Bristol-Myers Squibb (BMY)? 2/27/2017 5:49:06 AM
Drug Giants Like AbbVie (ABBV), Bristol-Myers Squibb (BMY) and Gilead (GILD) Turn to Well-Known Professors to Justify Its Outrageous Drug Prices 2/24/2017 5:58:42 AM
Bristol-Myers Squibb (BMY) Prices $1.5 Billion Of Senior Notes 2/23/2017 7:12:55 AM
Carl Icahn Can't Make Bristol-Myers Squibb (BMY) Buyable 2/23/2017 6:09:38 AM
The 5 Drug Giants That Could Snap Up a Struggling Bristol-Myers Squibb (BMY) 2/23/2017 5:43:16 AM
Serial Investor Carl Icahn Takes Stake in Bristol-Myers Squibb (BMY), Stock Jumps 2/22/2017 5:15:59 AM
Zoning Changes Kills Sale of Bristol-Myers Squibb (BMY)'s Connecticut Campus 2/21/2017 5:59:30 AM
Rumored Acquisition Target Bristol-Myers Squibb (BMY) Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback 2/21/2017 5:47:34 AM
12345678910...
//-->